157 related articles for article (PubMed ID: 35818732)
1. YAP1-NUTM1 Gene Fusion in Eccrine Porocarcinoma with Late Metastatic Recurrence: A Case Report.
Tormo-Mainar S; Vidal J; Salido M; Pujol RM; Deza G
Acta Derm Venereol; 2022 Jul; 102():adv00752. PubMed ID: 35818732
[No Abstract] [Full Text] [Related]
2. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
[TBL] [Abstract][Full Text] [Related]
3. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
Christensen DJ; Tuluc M
J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
[TBL] [Abstract][Full Text] [Related]
4. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
Li P; Busam KJ
J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
[TBL] [Abstract][Full Text] [Related]
5. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
6. YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
[TBL] [Abstract][Full Text] [Related]
7. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
9. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
[TBL] [Abstract][Full Text] [Related]
10. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
11. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
[TBL] [Abstract][Full Text] [Related]
12. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
13. Eccrine porocarcinoma arising within an area of Bowen disease.
Lowney AC; Mc Aleer MA; O'Connor K; Fitzgibbon JF; Bourke JF
Clin Exp Dermatol; 2012 Mar; 37(2):136-8. PubMed ID: 21973218
[TBL] [Abstract][Full Text] [Related]
14. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
Hartsough EM; Moran J; Devins K; Wszolek M; Cornejo KM
Am J Dermatopathol; 2023 Jan; 45(1):51-55. PubMed ID: 36484607
[TBL] [Abstract][Full Text] [Related]
15. Case report of eccrine porocarcinoma in situ associated with eccrine poroma on the forehead.
Wen SY
J Dermatol; 2012 Jul; 39(7):649-51. PubMed ID: 22150617
[No Abstract] [Full Text] [Related]
16. Recurrent Metastatic Eccrine Porocarcinoma: A Case Report and Review of the Literature.
Khaja M; Ashraf U; Mehershahi S; Ayyadurai P; Malik S
Am J Case Rep; 2019 Feb; 20():179-183. PubMed ID: 30739904
[TBL] [Abstract][Full Text] [Related]
17. A case of eccrine porocarcinoma characterized by a progressive increase in the level of Ki-67 index: case report and review of literature.
Shen J; Pan X; Lu Y; Pan D; Ma Y; Zhan R
BMC Surg; 2019 Oct; 19(1):142. PubMed ID: 31601219
[TBL] [Abstract][Full Text] [Related]
18. Concomitant poroma and porocarcinoma.
Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
[TBL] [Abstract][Full Text] [Related]
19. [Sweat gland eccrine porocarcinoma of the face: a rare annexal tumor].
Lakouichmi M; El Bouihi M; Zrara I; Lahmiti S; Hattab NM
Pan Afr Med J; 2013; 14():135. PubMed ID: 23734280
[TBL] [Abstract][Full Text] [Related]
20. Primary eccrine porocarcinoma of the finger with transit forearm and axillary metastasis.
Bhat W; Akhtar S; Khotwal A; Platt AJ
Ann Plast Surg; 2011 Apr; 66(4):344-6. PubMed ID: 21042176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
